Evidence map›Paper›PMID 41486439›Full record

ArticleInfection & chemotherapy2025

Serotype Distribution, Antimicrobial Susceptibility, and Genome Profile of

Miftahuddin Majid Khoeri, Korrie Salsabila, Lindawati Alimsardjono, Iva Puspitasari, Rina Yunita, Wisnu Tafroji, Naritha Vermasari, Wisiva Tofriska Paramaiswari, Yayah Winarti, Wa Ode Dwi Daningrat and 4 more

Abstract read
In one paragraph

Article in Infection & chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Miftahuddin Majid Khoeri *Doctoral Program in Biomedical, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.ORCID https://orcid.org/0000-0002-8862-6707
Korrie Salsabila *Advanced Medicine and Pharmacy, Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Japan.ORCID https://orcid.org/0000-0003-2866-678X
Lindawati AlimsardjonoDr. Soetomo General Academic Hospital, Surabaya, East Java, Indonesia.ORCID https://orcid.org/0000-0003-2771-4102
Iva PuspitasariDr. Kariadi General Hospital, Semarang, Central Java, Indonesia.ORCID https://orcid.org/0000-0003-3591-9255
Rina YunitaHaji Adam Malik Hospital, Medan, North Sumatera, Indonesia.ORCID https://orcid.org/0000-0001-5426-064X
Wisnu TafrojiIndonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.ORCID https://orcid.org/0000-0003-0622-7022
Naritha VermasariDr. Soetomo General Academic Hospital, Surabaya, East Java, Indonesia.ORCID https://orcid.org/0009-0001-7585-3476
Wisiva Tofriska ParamaiswariIndonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.ORCID https://orcid.org/0000-0003-2808-5248
Yayah WinartiIndonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.ORCID https://orcid.org/0000-0001-5576-417X
Wa Ode Dwi DaningratCentre for Genomic Pathogen Surveillance, Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-2341-5404
Amin SoebandrioDepartement of Clinical Microbiology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.ORCID https://orcid.org/0000-0002-5856-4808
Ratna Fathma SariEijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Cibinong, West Java, Indonesia.ORCID https://orcid.org/0000-0002-3413-3149
Yustinus MaladanEijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Cibinong, West Java, Indonesia.ORCID https://orcid.org/0000-0002-6685-7790
Dodi SafariEijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Cibinong, West Java, Indonesia. dodi004@brin.go.id.ORCID https://orcid.org/0000-0002-7639-7441

Funding

Badan Riset dan Inovasi NasionalCDC HHS NU2GGH001852-03
6 · The paper itself

Abstract

backgroundPneumococcal conjugate vaccine (PCV) was introduced as a part of national immunization program to prevent invasive pneumococcal diseases in Indonesia in 2022. This study aims to investigate the serotype distribution, antimicrobial susceptibility, and genome profile of MATERIALS AND

methods

results

conclusionSerotype 19F were the most common among vaccine-type serotype strains isolated from hospitalized patients prior to PCV introduction in Indonesia.

Indexed as

Invasive pneumococcal diseaseSerotype distribution, antimicrobial resistant profile, IndonesiaStreptococcus pneumoniae

Identifiers

PMID41486439
PMCPMC12802066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.